Avery Dennison Corp 10-Q for FY2024 Q1
Avery Dennison Corp (AVY)
10-Q
2024-04-30
For: 2024-03-30
View Original
Added on
April 09, 2026
About this 10-Q
Avery Dennison Corp filed this 10-Q on April 30, 2024, covering the quarter ended March 30, 2024 (FY2024 Q1).
Headline figures
Quarter ended March 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $2.15B
- up 4.2% from $2.07B a year earlier
- Net income
- $172.4M
- up 42.2% from net income of $121.2M a year earlier
- Diluted EPS
- $2.13
- up 43.0% from $1.49 a year earlier
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-Q
(Mark One)
| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||
For the quarterly period ended March 30, 2024 .
OR
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||
For the transition period from ________________________ to ________________________
Commission file number 1-7685
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||
| (Address of Principal Executive Offices) | (Zip Code) | |||||||
Registrant’s telephone number, including area code: (440 ) 534-6000
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
x | o Accelerated filer | o Non-accelerated filer | ||||||||||||||||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No x
Number of shares of $1 par value common stock outstanding as of April 27, 2024: 80,553,349
AVERY DENNISON CORPORATION
FISCAL FIRST QUARTER 2024 QUARTERLY REPORT ON FORM 10-Q
TABLE OF CONTENTS
| Page | ||||||||
| Exhibits | ||||||||
Safe Harbor Statement
This Quarterly Report contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements, which are not statements of historical fact, contain estimates, assumptions, projections and/or expectations regarding future events, which may or may not occur. Words such as “aim,” “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “foresee,” “guidance,” “intend,” “may,” “might,” “objective,” “plan,” “potential,” “project,” “seek,” “shall,” “should,” “target,” “will,” “would,” or variations thereof, and other expressions that refer to future events and trends, identify forward-looking statements. Our forward-looking statements, and financial or other business targets, are subject to certain risks and uncertainties, which could cause our actual results to differ materially from the expected results, performance or achievements expressed or implied by such forward-looking statements.
We believe that the most significant risk factors that could affect our financial performance in the near term include: (i) the impacts to underlying demand for our products from global economic conditions, political uncertainty, and changes in environmental standards and governmental regulations; (ii) competitors’ actions, including pricing, expansion in key markets, and product offerings; (iii) the cost and availability of raw materials; (iv) the degree to which higher costs can be offset with productivity measures and/or passed on to customers through price increases, without a significant loss of volume; (v) foreign currency fluctuations; and (vi) the execution and integration of acquisitions.
Certain risks and uncertainties are discussed in more detail under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our 2023 Annual Report on Form 10-K filed on February 21, 2024. Actual results and trends may differ materially from historical or anticipated results depending on a variety of factors, including but not limited to, risks and uncertainties related to the following:
•International Operations – worldwide economic, social, political and market conditions; changes in political conditions, including those related to China, the Russia-Ukraine war, the Israel-Hamas war and related hostilities in the Middle East; fluctuations in foreign currency exchange rates; and other risks associated with international operations, including in emerging markets
•Our Business – fluctuations in demand affecting sales to customers; fluctuations in the cost and availability of raw materials and energy; changes in our markets due to competitive conditions, technological developments, laws and regulations, tariffs and customer preferences; increasing environmental standards; the impact of competitive products and pricing; execution and integration of acquisitions; selling prices; customer and supplier concentrations or consolidations; financial condition of distributors; outsourced manufacturers; product and service quality; restructuring and other productivity actions; timely development and market acceptance of new products, including sustainable or sustainably-sourced products; investment in development activities and new production facilities; successful implementation of new manufacturing technologies and installation of manufacturing equipment; our ability to generate sustained productivity improvement; our ability to achieve and sustain targeted cost reductions; collection of receivables from customers; our sustainability and governance practices; and epidemics, pandemics or other outbreaks of illness
•Information Technology – disruptions in information technology systems, cyber attacks or other security breaches; and successful installation of new or upgraded information technology systems
•Income Taxes – fluctuations in tax rates; changes in tax laws and regulations, and uncertainties associated with interpretations of such laws and regulations; retention of tax incentives; outcome of tax audits; and the realization of deferred tax assets
•Human Capital – recruitment and retention of employees and collective labor arrangements
•Our Indebtedness – credit risks; our ability to obtain adequate financing arrangements and maintain access to capital; fluctuations in interest rates; volatility in financial markets; and compliance with our debt covenants
•Ownership of Our Stock – potential significant variability of our stock price and amounts of future dividends and share repurchases
•Legal and Regulatory Matters – protection and infringement of intellectual property; impact of legal and regulatory proceedings, including with respect to environmental, compliance and anti-corruption, environmental, health and safety, and trade compliance
•Other Financial Matters – fluctuations in pension costs and goodwill impairment
Our forward-looking statements are made only as of the date of this Form 10-Q. We assume no duty to update these forward-looking statements to reflect new, changed or unanticipated events or circumstances, other than as may be required by law.
1
Avery Dennison Corporation
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
| (Dollars in millions, except per share amount) | March 30, 2024 | December 30, 2023 | |||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | $ | |||||||||
Trade accounts receivable, less allowances of $ | |||||||||||
| Inventories | |||||||||||
| Other current assets | |||||||||||
| Total current assets | |||||||||||
| Property, plant and equipment, net | |||||||||||
| Goodwill | |||||||||||
| Other intangibles resulting from business acquisitions, net | |||||||||||
| Deferred tax assets | |||||||||||
| Other assets | |||||||||||
| $ | $ | ||||||||||
| Liabilities and Shareholders’ Equity | |||||||||||
| Current liabilities: | |||||||||||
| Short-term borrowings and current portion of long-term debt and finance leases | $ | $ | |||||||||
| Accounts payable | |||||||||||
| Accrued payroll and employee benefits | |||||||||||
| Other current liabilities | |||||||||||
| Total current liabilities | |||||||||||
| Long-term debt and finance leases | |||||||||||
| Long-term retirement benefits and other liabilities | |||||||||||
| Deferred tax liabilities and income taxes payable | |||||||||||
Commitments and contingencies (see Note 10) | |||||||||||
| Shareholders’ equity: | |||||||||||
Common stock, $ | |||||||||||
| Capital in excess of par value | |||||||||||
| Retained earnings | |||||||||||
Treasury stock at cost, | ( | ( | |||||||||
| Accumulated other comprehensive loss | ( | ( | |||||||||
| Total shareholders’ equity | |||||||||||
| $ | $ | ||||||||||
See Notes to Unaudited Condensed Consolidated Financial Statements
2
Avery Dennison Corporation
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
| Three Months Ended | |||||||||||||||||||||||
| (In millions, except per share amounts) | March 30, 2024 | April 1, 2023 | |||||||||||||||||||||
| Net sales | $ | $ | |||||||||||||||||||||
| Cost of products sold | |||||||||||||||||||||||
| Gross profit | |||||||||||||||||||||||
| Marketing, general and administrative expense | |||||||||||||||||||||||
| Other expense (income), net | |||||||||||||||||||||||
| Interest expense | |||||||||||||||||||||||
| Other non-operating expense (income), net | ( | ( | |||||||||||||||||||||
| Income before taxes | |||||||||||||||||||||||
| Provision for income taxes | |||||||||||||||||||||||
| Net income | $ | $ | |||||||||||||||||||||
| Per share amounts: | |||||||||||||||||||||||
| Net income per common share | $ | $ | |||||||||||||||||||||
| Net income per common share, assuming dilution | $ | $ | |||||||||||||||||||||
| Weighted average number of shares outstanding: | |||||||||||||||||||||||
| Common shares | |||||||||||||||||||||||
| Common shares, assuming dilution | |||||||||||||||||||||||
See Notes to Unaudited Condensed Consolidated Financial Statements
3
Avery Dennison Corporation
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
| Three Months Ended | |||||||||||||||||||||||
| (In millions) | March 30, 2024 | April 1, 2023 | |||||||||||||||||||||
| Net income | $ | $ | |||||||||||||||||||||
| Other comprehensive income (loss), net of tax: | |||||||||||||||||||||||
| Foreign currency translation | ( | ||||||||||||||||||||||
| Pension and other postretirement benefits | ( | ||||||||||||||||||||||
| Cash flow hedges | ( | ||||||||||||||||||||||
| Other comprehensive income (loss), net of tax | ( | ||||||||||||||||||||||
| Total comprehensive income, net of tax | $ | $ | |||||||||||||||||||||
See Notes to Unaudited Condensed Consolidated Financial Statements
4
Avery Dennison Corporation
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
| Three Months Ended | |||||||||||
| (In millions) | March 30, 2024 | April 1, 2023 | |||||||||
| Operating Activities | |||||||||||
| Net income | $ | $ | |||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Depreciation | |||||||||||
| Amortization | |||||||||||
| Provision for credit losses and sales returns | |||||||||||
| Stock-based compensation | |||||||||||
| Deferred taxes and other non-cash taxes | ( | ( | |||||||||
| Other non-cash expense and loss (income and gain), net | |||||||||||
| Changes in assets and liabilities and other adjustments | ( | ( | |||||||||
| Net cash provided by operating activities | |||||||||||
| Investing Activities | |||||||||||
| Purchases of property, plant and equipment | ( | ( | |||||||||
| Purchases of software and other deferred charges | ( | ( | |||||||||
Purchases of Argentine Blue Chip Swap securities | ( | ||||||||||
Proceeds from sales of Argentine Blue Chip Swap securities | |||||||||||
| Proceeds from sales of property, plant and equipment | |||||||||||
| Proceeds from insurance and sales (purchases) of investments, net | ( | ||||||||||
| Payments for acquisitions, net of cash acquired, and venture investments | ( | ( | |||||||||
| Net cash used in investing activities | ( | ( | |||||||||
| Financing Activities | |||||||||||
| Net increase (decrease) in borrowings with maturities of three months or less | |||||||||||
| Additional long-term borrowings | |||||||||||
| Repayments of long-term debt and finance leases | ( | ( | |||||||||
| Dividends paid | ( | ( | |||||||||
| Share repurchases | ( | ( | |||||||||
| Net (tax withholding) proceeds related to stock-based compensation | ( | ( | |||||||||
| Other | ( | ||||||||||
Net cash (used in) provided by financing activities | ( | ||||||||||
| Effect of foreign currency translation on cash balances | ( | ( | |||||||||
| Increase (decrease) in cash and cash equivalents | ( | ||||||||||
| Cash and cash equivalents, beginning of year | |||||||||||
| Cash and cash equivalents, end of period | $ | $ | |||||||||
5
Avery Dennison Corporation
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 1. General
The unaudited Condensed Consolidated Financial Statements and related notes in this Quarterly Report on Form 10-Q are presented as permitted by Article 10 of Regulation S-X and do not contain certain information included in the audited Consolidated Financial Statements and related notes in our 2023 Annual Report on Form 10-K, which should be read in conjunction with this Quarterly Report on Form 10-Q. These unaudited Condensed Consolidated Financial Statements contain all adjustments of a normal and recurring nature necessary for a fair statement of our interim results. Interim results of operations are not necessarily indicative of future results. These unaudited Condensed Consolidated Financial Statements reflect our current estimates and assumptions affecting (i) our reported amounts of assets and liabilities and related disclosures as of the date of the financial statements and (ii) our reported amounts of sales and expenses during the reporting periods presented.
Fiscal Periods
The three months ended March 30, 2024 and April 1, 2023 each consisted of a thirteen-week period.
Note 2. Goodwill and Other Intangibles Resulting from Business Acquisitions
Changes in the net carrying amount of goodwill for the three months ended March 30, 2024 by reportable segment are shown below.
| (In millions) | Materials Group | Solutions Group | Total | ||||||||||||||||||||
Goodwill as of December 30, 2023 | $ | $ | $ | ||||||||||||||||||||
Acquisition adjustments(1) | ( | ( | |||||||||||||||||||||
| Translation adjustments | ( | ( | ( | ||||||||||||||||||||
Goodwill as of March 30, 2024 | $ | $ | $ | ||||||||||||||||||||
Amortization expense for finite-lived intangible assets resulting from business acquisitions was $22.4 million and $20.5 million for the three months ended March 30, 2024 and April 1, 2023, respectively.
Estimated future amortization expense related to existing finite-lived intangible assets for the remainder of fiscal year 2024 and for each of the next four fiscal years and thereafter is shown below.
| (In millions) | Estimated Amortization Expense | ||||
2024 (remainder of year) | $ | ||||
2025 | |||||
2026 | |||||
2027 | |||||
2028 | |||||
| 2029 and thereafter | |||||
Note 3. Debt
In the first quarter of 2024, we reclassified our €500 million senior notes due in the first quarter of 2025 from "Long-term debt and finance leases" to "Short-term borrowings and current portion of long-term debt and finance leases" in the unaudited Condensed Consolidated Balance Sheets.
The estimated fair value of our long-term debt is primarily based on the credit spread above U.S. Treasury securities or euro government bond securities, as applicable, on notes with similar rates, credit ratings and remaining maturities. The fair value of short-term borrowings, which include commercial paper issuances and short-term lines of credit, approximates their carrying value given the short duration of these obligations. The fair value of our total debt was $3.08 billion at March 30, 2024 and $3.11 billion at December 30, 2023. Fair values were determined based primarily on Level 2 inputs, which are inputs other than quoted prices in active markets that are either directly or indirectly observable.
Our $1.20 billion revolving credit facility (the “Revolver”) contains a financial covenant requiring that we maintain a specified ratio of total debt to a certain measure of income. As of both March 30, 2024 and December 30, 2023, we were in compliance with this financial covenant. No
6
Avery Dennison Corporation
Note 4. Cost Reduction Actions
2023 Actions
We recorded $6.0 million in restructuring charges, net of reversals, during the three months ended March 30, 2024. These charges consisted of severance and related costs for the reduction of approximately 100 positions at various locations across our company.
In the third quarter of 2023, we approved a restructuring plan (the “2023 Plan”) to further optimize the European footprint of our Materials Group reportable segment by reducing operations in a manufacturing facility in Belgium. The cumulative charges associated with the 2023 Plan, which we recorded in 2023, consisted of severance and related costs for the reduction of approximately 210 positions, as well as asset impairment charges. We do not anticipate additional charges related to the 2023 Plan and expect it to be substantially completed by mid-2025.
During the three months ended March 30, 2024, restructuring charges and payments were as follows:
| (In millions) | Accrual at December 30, 2023 | Charges, Net of Reversals | Cash Payments | Non-cash Impairment | Foreign Currency Translation | Accrual at March 30, 2024 | |||||||||||||||||||||||||||||
| 2023 Actions | |||||||||||||||||||||||||||||||||||
| Severance and related costs | $ | $ | $ | ( | $ | $ | ( | $ | |||||||||||||||||||||||||||
| Asset impairment charges | ( | ||||||||||||||||||||||||||||||||||
Lease cancellation charges | ( | ||||||||||||||||||||||||||||||||||
| Total | $ | $ | $ | ( | $ | ( | $ | ( | $ | ||||||||||||||||||||||||||
Accruals for severance and related costs, as well as lease cancellation charges, were included in “Other current liabilities” and "Long-term retirement benefits and other liabilities" in the unaudited Condensed Consolidated Balance Sheets. Asset impairment charges were based on the estimated market value of the assets, less selling costs, if applicable. Restructuring charges were included in “Other expense (income), net” in the unaudited Condensed Consolidated Statements of Income.
The table below shows the total amount of restructuring charges, net of reversals, incurred by reportable segment and Corporate.
| Three Months Ended | |||||||||||||||||||||||
| (In millions) | March 30, 2024 | April 1, 2023 | |||||||||||||||||||||
| Restructuring charges, net of reversals, by reportable segment and Corporate | |||||||||||||||||||||||
| Materials Group | $ | $ | |||||||||||||||||||||
| Solutions Group | |||||||||||||||||||||||
| Corporate | ( | ||||||||||||||||||||||
| Total | $ | $ | |||||||||||||||||||||
Note 5. Financial Instruments
We enter into foreign exchange hedge contracts to reduce the risk from foreign exchange rate fluctuations associated with our receivables, payables, loans and firm commitments denominated in certain foreign currencies that arise primarily as a result of our operations outside the U.S. We also enter into futures contracts to hedge certain price fluctuations for a portion of our anticipated domestic purchases of natural gas. The impact of these foreign exchange and commodities hedge activities on the unaudited Condensed Consolidated Financial Statements was not material.
In March 2020, we entered into U.S. dollar to euro cross-currency swap contracts with a total notional amount of $250 million to have the effect of converting the fixed-rate U.S. dollar-denominated debt to euro-denominated debt, including semiannual interest payments and the payment of principal at maturity. During the term of the contracts, which end on April 30, 2030, we pay fixed-rate interest in euros and receive fixed-rate interest in U.S. dollars. These contracts have been designated as cash flow hedges. The fair value of these contracts was $5.3 million and $2.3 million as of March 30, 2024 and December 30, 2023, respectively, which was included in "Other Assets" in the unaudited Condensed Consolidated Balance Sheets. Refer to Note 9, “Fair Value Measurements,” to the unaudited Condensed Consolidated Financial Statements for more information.
We recorded no ineffectiveness from our cross-currency swap to earnings during the three months ended March 30, 2024 or April 1, 2023.
7
Avery Dennison Corporation
Note 6. Taxes Based on Income
The following table summarizes our income before taxes, provision for income taxes, and effective tax rate:
| Three Months Ended | |||||||||||||||||||||||
| (Dollars in millions) | March 30, 2024 | April 1, 2023 | |||||||||||||||||||||
| Income before taxes | $ | $ | |||||||||||||||||||||
| Provision for income taxes | |||||||||||||||||||||||
| Effective tax rate | % | % | |||||||||||||||||||||
Our provision for income taxes for the three months ended March 30, 2024 included a net tax charge related to the tax on global intangible low-taxed income (“GILTI”) of our foreign subsidiaries and the recognition of foreign withholding taxes on current year earnings, partially offset by the benefit from foreign-derived intangible income (“FDII”). Our provision for income taxes for the three months ended March 30, 2024 was favorably affected by the tax impacts resulting from Blue Chip Swap transactions in Argentina, partially offset by tax charges driven by higher interest expense in a foreign jurisdiction.
Our provision for income taxes for the three months ended April 1, 2023 included a net tax charge related to the tax on GILTI of our foreign subsidiaries and the recognition of foreign withholding taxes on current year earnings, partially offset by the benefit from FDII. Our provision for income taxes for the three months ended April 1, 2023 was also adversely affected by higher non-deductible expenses primarily driven by foreign currency and interest rate fluctuations, as well as lower tax incentives in certain foreign jurisdictions.
The amount of income taxes we pay is subject to ongoing audits by taxing jurisdictions around the world. Our estimate of the potential outcome of any uncertain tax issue is subject to our assessment of the relevant risks, facts and circumstances existing at the time. We believe that we have adequately provided for reasonably foreseeable outcomes related to these matters. However, our future results may include favorable or unfavorable adjustments to our estimated tax liabilities in the period the assessments are made or resolved, which may impact our effective tax rate. The final determination of tax audits and any related legal proceedings could materially differ from the amounts currently reflected in our tax provision for income taxes and the related liabilities. We and our U.S. subsidiaries have completed the IRS Compliance Assurance Process through 2021. With limited exceptions, we are no longer subject to income tax examinations by tax authorities for years prior to 2010.
It is reasonably possible that, during the next 12 months, we may realize a net decrease in our uncertain tax positions, including interest and penalties, of approximately $6 million, primarily as a result of closing tax years.
Note 7. Net Income Per Common Share
Net income per common share was computed as follows:
| Three Months Ended | |||||||||||||||||||||||
| (In millions, except per share amounts) | March 30, 2024 | April 1, 2023 | |||||||||||||||||||||
(A)Net income | $ | $ | |||||||||||||||||||||
(B)Weighted average number of common shares outstanding | |||||||||||||||||||||||
Dilutive shares (additional common shares issuable under stock-based awards) | |||||||||||||||||||||||
(C) Weighted average number of common shares outstanding, assuming dilution | |||||||||||||||||||||||
| Net income per common share: (A) ÷ (B) | $ | $ | |||||||||||||||||||||
| Net income per common share, assuming dilution: (A) ÷ (C) | $ | $ | |||||||||||||||||||||
Certain stock-based compensation awards were excluded from the computation of net income per common share, assuming dilution, because they would not have had a dilutive effect. Stock-based compensation awards excluded from the computation totaled 0.1 million shares for the three months ended March 30, 2024 and were no t significant for the three months ended April 1, 2023.
8
Avery Dennison Corporation
Note 8. Supplemental Equity and Comprehensive Income Information
Consolidated Changes in Shareholders’ Equity
| Three Months Ended | |||||||||||||||||||||||
| (In millions) | March 30, 2024 | April 1, 2023 | |||||||||||||||||||||
Common stock issued, $ | $ | $ | |||||||||||||||||||||
| Capital in excess of par value | |||||||||||||||||||||||
| Beginning balance | $ | $ | |||||||||||||||||||||
Issuance of shares under stock-based compensation plans(1) | ( | ( | |||||||||||||||||||||
| Ending balance | $ | $ | |||||||||||||||||||||
| Retained earnings | |||||||||||||||||||||||
| Beginning balance | $ | $ | |||||||||||||||||||||
| Net income | |||||||||||||||||||||||
Issuance of shares under stock-based compensation plans(1) | |||||||||||||||||||||||
Contribution of shares to 401(k) plan(1) | |||||||||||||||||||||||
| Dividends | ( | ( | |||||||||||||||||||||
| Ending balance | $ | $ | |||||||||||||||||||||
| Treasury stock at cost | |||||||||||||||||||||||
| Beginning balance | $ | ( | $ | ( | |||||||||||||||||||
| Repurchase of shares for treasury | ( | ( | |||||||||||||||||||||
Issuance of shares under stock-based compensation plans(1) | |||||||||||||||||||||||
Contribution of shares to 401(k) plan(1) | |||||||||||||||||||||||
| Ending balance | $ | ( | $ | ( | |||||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||||||||
| Beginning balance | $ | ( | $ | ( | |||||||||||||||||||
| Other comprehensive income (loss), net of tax | ( | ||||||||||||||||||||||
| Ending balance | $ | ( | $ | ( | |||||||||||||||||||
Dividends per common share were as follows:
| Three Months Ended | |||||||||||||||||||||||
| March 30, 2024 | April 1, 2023 | ||||||||||||||||||||||
| Dividends per common share | $ | $ | |||||||||||||||||||||
9
Avery Dennison Corporation
Changes in Accumulated Other Comprehensive Loss
The changes in “Accumulated other comprehensive loss” (net of tax) for the three-month period ended March 30, 2024 were as follows:
| (In millions) | Foreign Currency Translation | Pension and Other Postretirement Benefits | Cash Flow Hedges | Total | |||||||||||||||||||
Balance as of December 30, 2023 | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
| Other comprehensive income (loss) before reclassifications, net of tax | ( | ( | ( | ||||||||||||||||||||
| Reclassifications to net income, net of tax | |||||||||||||||||||||||
| Other comprehensive income (loss), net of tax | ( | ( | ( | ||||||||||||||||||||
Balance as of March 30, 2024 | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
The changes in “Accumulated other comprehensive loss” (net of tax) for the three-month period ended April 1, 2023 were as follows:
| (In millions) | Foreign Currency Translation | Pension and Other Postretirement Benefits | Cash Flow Hedges | Total | |||||||||||||||||||
Balance as of December 31, 2022 | $ | ( | $ | ( | $ | $ | ( | ||||||||||||||||
| Other comprehensive income (loss) before reclassifications, net of tax | |||||||||||||||||||||||
| Reclassifications to net income, net of tax | ( | ||||||||||||||||||||||
| Other comprehensive income (loss), net of tax | ( | ||||||||||||||||||||||
Balance as of April 1, 2023 | $ | ( | $ | ( | $ | $ | ( | ||||||||||||||||
Note 9. Fair Value Measurements
Recurring Fair Value Measurements
Assets and liabilities carried at fair value, measured on a recurring basis, as of March 30, 2024 were as follows:
| Fair Value Measurements Using | |||||||||||||||||||||||
| (In millions) | Total | Quoted Prices in Active Markets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Other Unobservable Inputs (Level 3) | |||||||||||||||||||
| Assets | |||||||||||||||||||||||
| Investments | $ | $ | $ | $ | |||||||||||||||||||
| Bank drafts | |||||||||||||||||||||||
| Cross-currency swap | |||||||||||||||||||||||
| Liabilities | |||||||||||||||||||||||
| $ | $ | $ | $ | ||||||||||||||||||||
| Contingent consideration liabilities | |||||||||||||||||||||||
10
Avery Dennison Corporation
Assets and liabilities carried at fair value, measured on a recurring basis, as of December 30, 2023 were as follows:
| Fair Value Measurements Using | |||||||||||||||||||||||
| (In millions) | Total | Quoted Prices in Active Markets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Other Unobservable Inputs (Level 3) | |||||||||||||||||||
| Assets | |||||||||||||||||||||||
| Investments | $ | $ | $ | $ | |||||||||||||||||||
| Derivative assets | |||||||||||||||||||||||
| Bank drafts | |||||||||||||||||||||||
| Cross-currency swap | |||||||||||||||||||||||
| Liabilities | |||||||||||||||||||||||
| Derivative liabilities | $ | $ | $ | $ | |||||||||||||||||||
| Contingent consideration liabilities | |||||||||||||||||||||||
Investments include fixed income securities (primarily U.S. government and corporate debt securities) measured at fair value using quoted prices/bids and a money market fund measured at fair value using net asset value. As of March 30, 2024, investments of $2.1 million and $36.0 million were included in “Cash and cash equivalents” and “Other current assets,” respectively, in the unaudited Condensed Consolidated Balance Sheets. As of December 30, 2023, investments of $2.7 million and $35.1 million were included in “Cash and cash equivalents” and “Other current assets,” respectively, in the unaudited Condensed Consolidated Balance Sheets. Derivatives that are exchange-traded are measured at fair value using quoted market prices and classified within Level 1 of the valuation hierarchy. Derivatives measured based on foreign exchange rate inputs that are readily available in public markets are classified within Level 2 of the valuation hierarchy. Bank drafts (maturities greater than three months) are valued at face value due to their short-term nature and were included in “Other current assets” in the unaudited Condensed Consolidated Balance Sheets.
Contingent consideration liabilities as of March 30, 2024 relate to estimated earn-out payments associated with certain acquisitions completed in 2023, 2022 and 2021, which are subject to the acquired companies achieving certain post-acquisition performance targets. These liabilities were recorded based on the expected payments and have been classified as Level 3. Activity related to contingent consideration was immaterial for the three months ended March 30, 2024 and April 1, 2023.
Note 10. Commitments and Contingencies
Legal Proceedings
We are involved in various lawsuits, claims, inquiries and other regulatory and compliance matters, most of which are routine to the nature of our business. When it is probable that a loss will be incurred and where a range of the loss can be reasonably estimated, the best estimate within the range is accrued. When the best estimate within the range cannot be determined, the low end of the range is accrued. The ultimate resolution of these claims could affect future results of operations should our exposure be materially different from our estimates or should we incur liabilities that were not previously accrued. Potential insurance reimbursements are not offset against potential liabilities.
We were party to a litigation in which ADASA Inc. (“Adasa”), an unrelated third party, alleged that certain of our RFID products within our Solutions Group reportable segment infringed its patent. The case was filed on October 24, 2017 in the United States District Court in the District of Oregon (Eugene Division) and was captioned ADASA Inc. v. Avery Dennison Corporation. We recorded a contingent liability in the amount of $26.6 million related to this matter in the second quarter of 2021 based on a jury verdict issued on May 14, 2021.
We appealed the first instance judgment associated with the jury verdict – which resulted in additional potential liability for the RFID tags sold during the period from the jury verdict to the issuance of the first instance judgment, a higher royalty imposed by the judge applicable to tags sold after the judgment and a royalty on additional late-disclosed tags, as well as sanctions, prejudgment interest, costs, and attorneys’ fees, as well as an ongoing royalty on in-scope tags sold after October 14, 2021 – to the United States Court of Appeals for the Federal Circuit (the “CAFC”). During the fourth quarter of 2022, the CAFC issued its opinion, reversing the grant of summary judgment of validity as to anticipation and obviousness, vacating the sanctions ruling, and remanding the case for retrial with respect to validity for anticipation and obviousness over the prior art. The CAFC affirmed subject-matter eligibility and damages if liability was
11
Avery Dennison Corporation
determined on retrial. On remand, the trial court was required to reconsider the amount of sanctions consistent with the CAFC's instruction to limit sanctions to the late-disclosed tags.
After the U.S. Supreme Court denied our writ of certiorari petition on May 30, 2023, the trial court’s retrial began on July 10, 2023. On July 18, 2023, the jury in the retrial issued a verdict that Adasa’s patent is valid. We increased our contingent liability to reflect our then-best estimate of the anticipated judgment to $80.4 million as of July 1, 2023, with an expectation to continue adjusting our accrual quarterly, as appropriate. As of December 30, 2023, our contingent liability for this matter was $82.9 million.
On January 25, 2024, the district court issued a revised sanction order lowering the sanction against us from approximately $20 million to $5.2 million, based on a rate of $0.0025 /late-reported tag, which was consistent with the amount we had accrued. In February 2024, the district court issued its decision denying our motion for judgment as a matter of law and our motion for a new trial. On March 7, 2024, the Court issued an amended final judgment, assessing damages, pre- and post-judgment interest, costs, attorneys' fees, sanctions, and on-going royalties.
Subsequent to the end of the first quarter of 2024, on April 25, 2024, we executed a Settlement Agreement, License and Mutual Release with Adasa pursuant to which, among other things, (i) we agreed to pay $75.0 million to Adasa without any concessions or admissions of liability; (ii) Adasa agreed to grant us a worldwide, nonexclusive, nontransferable fully-paid up, and ongoing royalty-free perpetual license, without the right to sublicense, to the patents at issue in the litigation; and (iii) the parties mutually released all claims against one another. We paid the agreed-upon settlement amount to Adasa on April 26, 2024. No court approval of the settlement is required, however, as required by the settlement agreement, Adasa filed a Stipulation of Satisfaction of Judgment with the trial court on April 29, 2024.
Because of the uncertainties associated with claims resolution and litigation, future expenses to resolve legal proceedings could be higher than the liabilities we have accrued; however, we are unable to reasonably estimate a range of potential expenses. If information were to become available that allowed us to reasonably estimate a range of potential expenses determined to be probable in an amount higher or lower than what we have accrued, we would adjust our accrued liabilities accordingly. Additional lawsuits, claims, inquiries and other regulatory and compliance matters could arise in the future. The range of expenses for resolving any future matters would be assessed as they arise; until then, a range of potential expenses for their resolution cannot be determined. Based upon current information, we believe that the impact of the resolution of legal proceedings would not be, individually or in the aggregate, material to our financial position, results of operations or cash flows.
Environmental Expenditures
Environmental expenditures are generally expensed. When it is probable that a loss will be incurred and where a range of the loss can be reasonably estimated, the best estimate within the range is accrued. When the best estimate within the range cannot be determined, the low end of the range is accrued. The ultimate resolution of these matters could affect future results of operations should our exposure be materially different from our estimates or should we incur liabilities that were not previously accrued. Potential insurance reimbursements are not offset against potential liabilities. We review our estimates of the costs of complying with environmental laws related to remediation and cleanup of various sites, including sites in which governmental agencies have designated us as a potentially responsible party (“PRP”). However, environmental expenditures for newly acquired assets and those that extend or improve the economic useful life of existing assets are capitalized and amortized over the shorter of the estimated useful life of the acquired asset or the remaining life of the existing asset.
As of March 30, 2024, we have been designated by the U.S. Environmental Protection Agency (“EPA”) and/or other responsible state agencies as a PRP at eleven waste disposal or waste recycling sites that are the subject of separate investigations or proceedings concerning alleged soil and/or groundwater contamination. No settlement of our liability related to any of these sites has been agreed upon. We are participating with other PRPs at these sites and anticipate that our share of remediation costs will be determined pursuant to agreements that we negotiate with the EPA or other governmental authorities.
These estimates could change as a result of changes in planned remedial actions, remediation technologies, site conditions, the estimated time to complete remediation, environmental laws and regulations, and other factors. Because of the uncertainties associated with environmental assessment and remediation activities, our future expenses to remediate these sites could be higher than the liabilities we have accrued; however, we are unable to reasonably estimate a range of potential expenses determined to be probable. If information were to become available that allowed us to reasonably estimate a range of potential expenses in an amount higher or lower than what we have accrued, we would adjust our environmental liabilities accordingly. In addition, we may be identified as a PRP at additional sites in the future. The range of expenses for remediation of any future-identified sites would be addressed as they arise; until then, a range of expenses for their remediation cannot be determined.
The activity related to our for the three months ended March 30, 2024 is shown below.
| (In millions) | |||||
Balance at December 30, 2023 | $ | ||||
| Charges, net of reversals | |||||
| Payments | ( | ||||
Balance at March 30, 2024 | $ | ||||
12
Avery Dennison Corporation
Approximately $9 million and $11 million, respectively, of this balance was classified as short-term and included in “” in the unaudited Condensed Consolidated Balance Sheets as of March 30, 2024 and December 30, 2023.
Note 11. Segment and Disaggregated Revenue Information
Disaggregated Revenue Information
Disaggregated revenue information is shown below in the manner that best reflects how the nature, amount, timing and uncertainty of our revenue and cash flows are affected by economic factors. Revenue from our Materials Group reportable segment is attributed to geographic areas based on the location from which products are shipped. Revenue from our Solutions Group reportable segment is shown by product group.
| Three Months Ended | |||||||||||||||||||||||
| (In millions) | March 30, 2024 | April 1, 2023 | |||||||||||||||||||||
| Net sales to unaffiliated customers | |||||||||||||||||||||||
| Materials Group: | |||||||||||||||||||||||
| U.S. | $ | $ | |||||||||||||||||||||
Europe, the Middle East and North Africa | |||||||||||||||||||||||
| Asia | |||||||||||||||||||||||
| Latin America | |||||||||||||||||||||||
Other | |||||||||||||||||||||||
| Total Materials Group | |||||||||||||||||||||||
| Solutions Group: | |||||||||||||||||||||||
| Apparel | |||||||||||||||||||||||
| Identification Solutions and Vestcom | |||||||||||||||||||||||
| Total Solutions Group | |||||||||||||||||||||||
| Net sales to unaffiliated customers | $ | $ | |||||||||||||||||||||
Additional Segment Information
Additional financial information by reportable segment and Corporate is shown below.
| Three Months Ended | |||||||||||||||||||||||
| (In millions) | March 30, 2024 | April 1, 2023 | |||||||||||||||||||||
| Intersegment sales | |||||||||||||||||||||||
| Materials Group | $ | $ | |||||||||||||||||||||
| Solutions Group | |||||||||||||||||||||||
| Intersegment sales | $ | $ | |||||||||||||||||||||
| Income before taxes | |||||||||||||||||||||||
| Materials Group | $ | $ | |||||||||||||||||||||
| Solutions Group | |||||||||||||||||||||||
| Corporate expense | ( | ( | |||||||||||||||||||||
| Interest expense | ( | ( | |||||||||||||||||||||
| Other non-operating expense (income), net | |||||||||||||||||||||||
| Income before taxes | $ | $ | |||||||||||||||||||||
| Other expense (income), net, by reportable segment and Corporate | |||||||||||||||||||||||
| Materials Group | $ | $ | |||||||||||||||||||||
| Solutions Group | ( | ||||||||||||||||||||||
| Corporate | ( | ||||||||||||||||||||||
| Other expense (income), net | $ | $ | |||||||||||||||||||||
13
Avery Dennison Corporation
Other expense (income), net, by type were as follows:
| Three Months Ended | |||||||||||||||||||||||
| (In millions) | March 30, 2024 | April 1, 2023 | |||||||||||||||||||||
| Other expense (income), net, by type | |||||||||||||||||||||||
Restructuring charges, net of reversals: | |||||||||||||||||||||||
Severance and related costs, net of reversals | $ | $ | |||||||||||||||||||||
Asset impairment and lease cancellation charges | |||||||||||||||||||||||
| Other items: | |||||||||||||||||||||||
Losses from Argentine peso remeasurement and Blue Chip Swap transactions | |||||||||||||||||||||||
| (Gain) loss on venture investment | |||||||||||||||||||||||
| Outcomes of legal matters and settlements, net | ( | ||||||||||||||||||||||
| Transaction and related costs | |||||||||||||||||||||||
| Other expense (income), net | $ | $ | |||||||||||||||||||||
Note 12. Supplemental Financial Information
Inventories
The table below summarizes amounts in inventories.
| (In millions) | March 30, 2024 | December 30, 2023 | |||||||||
| Raw materials | $ | $ | |||||||||
| Work-in-progress | |||||||||||
| Finished goods | |||||||||||
| Inventories | $ | $ | |||||||||
Property, Plant and Equipment, Net
The table below summarizes the amounts in property, plant and equipment, net.
| (In millions) | March 30, 2024 | December 30, 2023 | |||||||||
| Property, plant and equipment | $ | $ | |||||||||
| Accumulated depreciation | ( | ( | |||||||||
| Property, plant and equipment, net | $ | $ | |||||||||
Allowance for Credit Losses
The activity related to our allowance for credit losses is shown below.
| Three Months Ended | |||||||||||
| (In millions) | March 30, 2024 | April 1, 2023 | |||||||||
| Beginning balance | $ | $ | |||||||||
Provision for credit losses | |||||||||||
| Amounts written off | ( | ( | |||||||||
| Other, including foreign currency translation | ( | ||||||||||
| Ending balance | $ | $ | |||||||||
14
Avery Dennison Corporation
Supplier Finance Programs
We have agreements with third-party financial institutions to facilitate payments to suppliers. These third-party financial institutions offer voluntary supply chain finance programs that enable certain of our suppliers, at the supplier’s sole discretion, to sell our payment obligations to a financial institution on terms directly negotiated with the financial institution. Participating suppliers decide which payment obligations are sold to the financial institution and we have no economic interest in a supplier’s decision to sell these payment obligations. We make payments to the financial institution on the invoice due date, regardless of whether an individual invoice is sold by the supplier to the financial institution. Our obligations to our suppliers, including amounts due and scheduled payment dates, are not impacted by suppliers' decisions to sell amounts under these arrangements. Amounts due under our supply chain finance programs are included in accounts payable on our unaudited Condensed Consolidated Balance Sheets and activities related to these programs are presented as operating activities in our unaudited Condensed Consolidated Statements of Cash Flows. As of March 30, 2024 and December 30, 2023, the amounts due to financial institutions for suppliers that participate in these programs were $383.0 million and $397.4 million, respectively.
Argentine Blue Chip Swap
During 2019, the Argentine government instituted exchange controls restricting the ability of entities and individuals to exchange Argentine pesos for foreign currencies or remit foreign currency out of Argentina. Due to these currency exchange restrictions, markets in Argentina use a legal trading mechanism known as the Blue Chip Swap that allows entities to transfer U.S. dollars in and out of Argentina. During the first quarter of 2024, we entered into Blue Chip Swap transactions that resulted in losses of approximately $6 million that we recorded in "Other expense (income), net" in the unaudited Condensed Consolidated Statements of Income. Purchases and the proceeds from sales of Argentine Blue Chip Swap securities are presented as investing activities in our unaudited Condensed Consolidated Statements of Cash Flows.
15
Avery Dennison Corporation
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Management’s Discussion and Analysis of Financial Condition and Results of Operations, or MD&A, provides management’s views on our financial condition and results of operations and should be read in conjunction with the accompanying unaudited Condensed Consolidated Financial Statements and related notes thereto.
NON-GAAP FINANCIAL MEASURES
We report our financial results in conformity with accounting principles generally accepted in the United States of America, or GAAP, and also communicate with investors using certain non-GAAP financial measures. These non-GAAP financial measures are not in accordance with, nor are they a substitute for or superior to, the comparable GAAP financial measures. These non-GAAP financial measures are intended to supplement the presentation of our financial results prepared in accordance with GAAP. We use these non-GAAP financial measures internally to evaluate trends in our underlying performance, as well as to facilitate comparisons with the results of competitors for quarters and year-to-date periods, as applicable. Based on feedback from investors and financial analysts, we believe that the supplemental non-GAAP financial measures we provide are also useful to their assessments of our performance and operating trends, as well as liquidity. Reconciliations of our non-GAAP financial measures from the most directly comparable GAAP financial measures are provided in accordance with Regulation G and S-K.
Our non-GAAP financial measures exclude the impact of certain events, activities or strategic decisions. The accounting effects of these events, activities or decisions, which are included in the GAAP financial measures, may make it more difficult to assess our underlying performance in a single period. By excluding the accounting effects, positive or negative, of certain items (e.g., restructuring charges, outcomes of certain legal matters and settlements, certain effects of strategic transactions and related costs, losses from debt extinguishments, gains or losses from curtailment or settlement of pension obligations, gains or losses on sales of certain assets, gains or losses on venture investments, currency adjustments due to highly inflationary economies, and other items), we believe that we are providing meaningful supplemental information that facilitates an understanding of our core operating results and liquidity measures. While some of the items we exclude from GAAP financial measures recur, they tend to be disparate in amount, frequency or timing.
We use the non-GAAP financial measures defined below in this MD&A.
•Sales change ex. currency refers to the increase or decrease in net sales, excluding the estimated impact of foreign currency translation and, where applicable, an extra week in our fiscal year, the calendar shift resulting from the extra week in the prior fiscal year, currency adjustments for transitional reporting of highly inflationary economies, and the reclassification of sales between segments. The estimated impact of foreign currency translation is calculated on a constant currency basis, with prior-period results translated at current period average exchange rates to exclude the effect of foreign currency fluctuations.
•Organic sales change refers to sales change ex. currency, excluding the estimated impact of acquisitions and product line divestitures.
We believe that sales change ex. currency and organic sales change assist investors in evaluating the sales change from the ongoing activities of our businesses and enhance their ability to evaluate our results from period to period.
•Adjusted free cash flow refers to cash flow provided by operating activities, less payments for property, plant and equipment, software and other deferred charges, plus proceeds from company-owned life insurance policies, plus proceeds from sales of property, plant and equipment, plus (minus) net proceeds from insurance and sales (purchases) of investments, less net cash used for Argentine Blue Chip Swap securities. Where applicable, adjusted free cash flow is also adjusted for certain acquisition-related transaction costs. We believe that adjusted free cash flow assists investors by showing the amount of cash we have available for debt reductions, dividends, share repurchases and acquisitions.
•Operational working capital as a percentage of annualized current quarter net sales refers to trade accounts receivable and inventories, net of accounts payable, and excludes cash and cash equivalents, short-term borrowings, deferred taxes, other current assets and other current liabilities, as well as net current assets or liabilities held-for-sale divided by annualized current quarter net sales. We believe that operational working capital as a percentage of annualized current quarter net sales assists investors in assessing our working capital requirements because it excludes the impact of fluctuations attributable to our financing and other activities (which affect cash and cash equivalents, deferred taxes, other current assets and other current liabilities) that tend to be disparate in amount, frequency or timing, and may increase the volatility of working capital as a percentage of sales from period to period. The items excluded from this measure are not significantly influenced by our day-to-day activities managed at the operating level and do not necessarily reflect the underlying trends in our operations.
16
Avery Dennison Corporation
OVERVIEW AND OUTLOOK
Net Sales
The factors impacting reported net sales change, as compared to the prior-year period, are shown in the table below.
Three Months Ended March 30, 2024 | |||||||||||
| Reported net sales change | 4 | % | |||||||||
| Foreign currency translation | — | ||||||||||
Sales change ex. currency(1) | 4 | ||||||||||
| Acquisitions | (1) | ||||||||||
Organic sales change(1) | 3 | % | |||||||||
(1) Totals may not sum due to rounding
In the three months ended March 30, 2024, net sales increased on an organic basis compared to the same period in the prior year primarily due to higher volume, partially offset by the impact of raw material deflation-related price reductions.
Net Income
Net income increased from approximately $121 million in the first three months of 2023 to approximately $172 million in the first three months of 2024. The major factors affecting this increase were:
•Higher volume
•Benefits from productivity initiatives, including material re-engineering and savings from restructuring actions, net of transition costs
Offsetting factors:
•Higher employee-related costs
•Higher provision for income taxes
Cost Reduction Actions
2023 Actions
We recorded $6.0 million in restructuring charges, net of reversals, during the three months ended March 30, 2024. These charges consisted of severance and related costs for the reduction of approximately 100 positions at various locations across our company.
In the third quarter of 2023, we approved a restructuring plan (the “2023 Plan”) to further optimize the European footprint of our Materials Group reportable segment by reducing operations in a manufacturing facility in Belgium. The cumulative charges associated with the 2023 Plan, which we recorded in 2023, consisted of severance and related costs for the reduction of approximately 210 positions, as well as asset impairment charges. We do not anticipate additional charges related to the 2023 Plan and expect it to be substantially completed by mid-2025.
Restructuring charges were included in “Other expense (income), net” in the unaudited Condensed Consolidated Statements of Income. Refer to Note 4, “Cost Reduction Actions,” to the unaudited Condensed Consolidated Financial Statements for more information.
Cash Flow
| Three Months Ended | |||||||||||
| (In millions) | March 30, 2024 | April 1, 2023 | |||||||||
| Net cash provided by operating activities | $ | 119.8 | $ | 1.9 | |||||||
| Purchases of property, plant and equipment | (48.8) | (64.5) | |||||||||
| Purchases of software and other deferred charges | (6.9) | (5.3) | |||||||||
Purchases of Argentine Blue Chip Swap securities | (20.2) | — | |||||||||
Proceeds from sales of Argentine Blue Chip Swap securities | 14.0 | — | |||||||||
| Proceeds from sales of property, plant and equipment | .1 | .2 | |||||||||
| Proceeds from insurance and sales (purchases) of investments, net | .1 | (3.5) | |||||||||
| Adjusted free cash flow | $ | 58.1 | $ | (71.2) | |||||||
17
Avery Dennison Corporation
During the first three months of 2024, net cash provided by operating activities increased compared to the same period last year primarily due to higher net income, lower incentive compensation payments and lower tax payments, net of refunds. During the first three months of 2024, adjusted free cash flow increased compared to the same period last year primarily due to an increase in net cash provided by operating activities and a decrease in purchases of property, plant and equipment.
Outlook
Certain factors that we believe may contribute to our 2024 results are described below.
•We anticipate net sales to increase due to higher volume as our markets improve following significant inventory destocking downstream from our company in 2023, as well as growth in Intelligent Labels. This increase may be partially offset with raw material deflation-related price reductions.
•We anticipate incremental savings from restructuring actions, net of transition costs.
•Based on recent rates, we expect a modestly unfavorable impact to our full-year operating income from foreign currency translation.
•We expect our full year effective tax rate to be in the mid-twenty percent range.
ANALYSIS OF RESULTS OF OPERATIONS FOR THE FIRST QUARTER
Income Before Taxes
Three Months Ended | |||||||||||
| (In millions, except percentages) | March 30, 2024 | April 1, 2023 | |||||||||
| Net sales | $ | 2,151.3 | $ | 2,065.0 | |||||||
| Cost of products sold | 1,519.1 | 1,522.7 | |||||||||
| Gross profit | 632.2 | 542.3 | |||||||||
| Marketing, general and administrative expense | 365.2 | 334.4 | |||||||||
| Other expense (income), net | 12.6 | 17.8 | |||||||||
| Interest expense | 28.6 | 26.4 | |||||||||
| Other non-operating expense (income), net | (8.6) | (4.6) | |||||||||
| Income before taxes | $ | 234.4 | $ | 168.3 | |||||||
| Gross profit margin | 29.4 | % | 26.3 | % | |||||||
Gross Profit Margin
Gross profit margin for the first quarter of 2024 increased from the same period last year due to benefits from productivity initiatives, including material re-engineering and savings from restructuring actions, net of transition costs, the net impact of pricing and raw material input costs, and higher volume, partially offset by higher employee-related costs.
Marketing, General and Administrative Expense
Marketing, general and administrative expense increased in the first quarter of 2024 compared to the same period last year primarily due to higher employee-related costs and growth investments, partially offset by the benefits from productivity initiatives, including savings from restructuring actions, net of transition costs.
18
Avery Dennison Corporation
Other Expense (Income), Net
| Three Months Ended | |||||||||||
| (In millions) | March 30, 2024 | April 1, 2023 | |||||||||
| Other expense (income), net, by type | |||||||||||
| Restructuring charges: | |||||||||||
Severance and related costs, net of reversals | $ | 4.9 | $ | 17.1 | |||||||
Asset impairment and lease cancellation charges | 1.1 | .5 | |||||||||
| Other items: | |||||||||||
| Losses from Argentine peso remeasurement and Blue Chip Swap transactions | 11.3 | — | |||||||||
(Gain) loss on venture investment | 2.2 | — | |||||||||
Outcomes of legal matters and settlements, net | (6.9) | — | |||||||||
| Transaction and related costs | — | .2 | |||||||||
| Other expense (income), net | $ | 12.6 | $ | 17.8 | |||||||
Refer to Note 4, “Cost Reduction Actions,” to the unaudited Condensed Consolidated Financial Statements for more information regarding restructuring charges. Refer to Note 10, “Commitments and Contingencies,” to the unaudited Condensed Consolidated Financial Statements for more information regarding the outcomes of legal matters and settlements, net.
Interest Expense
Interest expense increased in the first quarter of 2024 compared to the same period last year as a result of higher interest rates on borrowings and higher debt levels.
Net Income and Earnings per Share
Three Months Ended | |||||||||||
| (In millions, except per share amounts and percentages) | March 30, 2024 | April 1, 2023 | |||||||||
| Income before taxes | $ | 234.4 | $ | 168.3 | |||||||
| Provision for income taxes | 62.0 | 47.1 | |||||||||
| Net income | $ | 172.4 | $ | 121.2 | |||||||
| Per share amounts: | |||||||||||
| Net income per common share | $ | 2.14 | $ | 1.50 | |||||||
| Net income per common share, assuming dilution | 2.13 | 1.49 | |||||||||
| Effective tax rate | 26.5 | % | 28.0 | % | |||||||
Provision for Income Taxes
Our effective tax rate for the three months ended March 30, 2024 decreased compared to the same period last year primarily due to the tax impacts resulting from Blue Chip Swap transactions in Argentina. Refer to Note 6, “Taxes Based on Income,” to the unaudited Condensed Consolidated Financial Statements for more information.
The global minimum tax under the Pillar Two framework became effective for us in 2024. While the impact on our unaudited Condensed Consolidated Financial Statements is currently not material, our analysis is ongoing as the Organization for Economic Cooperation and Development continues to release additional guidance and countries enact related legislation.
Our effective tax rate can vary from period to period due to a variety of factors, such as changes in our mix of earnings in countries with differing statutory tax rates, changes in our tax reserves, settlements of income tax audits, changes in tax laws and regulations, return-to-provision adjustments, tax impacts related to stock-based payments, and our execution of tax planning strategies.
19
Avery Dennison Corporation
RESULTS OF OPERATIONS BY REPORTABLE SEGMENT FOR THE FIRST QUARTER
Operating income refers to income before taxes, interest and other non-operating expense (income), net.
Materials Group
Three Months Ended | |||||||||||
| (In millions) | March 30, 2024 | April 1, 2023 | |||||||||
| Net sales including intersegment sales | $ | 1,543.5 | $ | 1,495.4 | |||||||
| Less intersegment sales | (47.0) | (34.9) | |||||||||
| Net sales | $ | 1,496.5 | $ | 1,460.5 | |||||||
Operating income(1) | 226.1 | 160.5 | |||||||||
(1)Included charges associated with losses from Argentine peso remeasurement and Blue Chip Swap transactions and outcomes of legal matters and settlements, net, in 2024, and restructuring actions in both years | $ | 14.4 | $ | 14.3 | |||||||
Net Sales
The factors impacting reported net sales change are shown in the table below.
| Three Months Ended | |||||
| March 30, 2024 | |||||
Reported net sales change | 3 | % | |||
| Foreign currency translation | (1) | ||||
Sales change ex. currency(1) | 2 | ||||
Organic sales change(1) | 2 | % | |||
(1) Totals may not sum due to rounding. | |||||
In the first quarter of 2024, net sales increased on an organic basis compared to the same period in the prior year mainly due to higher volume/mix, partially offset by the impact of raw material deflation-related price reductions. On an organic basis, net sales increased by a low-to-mid single-digit rate in Western Europe and a mid single-digit rate in emerging markets, which was partially offset by a low single-digit rate decrease in North America.
Operating Income
Operating income increased in the first quarter of 2024 compared to the same period last year primarily due to benefits from productivity initiatives, including material re-engineering and savings from restructuring actions, net of transition costs, higher volume/mix and lower restructuring charges, partially offset by higher employee-related costs and losses from Argentine peso remeasurement and Blue Chip Swap transactions.
Solutions Group
Three Months Ended | |||||||||||
| (In millions) | March 30, 2024 | April 1, 2023 | |||||||||
| Net sales including intersegment sales | $ | 665.7 | $ | 614.5 | |||||||
| Less intersegment sales | (10.9) | (10.0) | |||||||||
| Net sales | $ | 654.8 | $ | 604.5 | |||||||
Operating income(1) | 56.1 | 51.5 | |||||||||
(1)Included charges associated with loss on venture investment and outcomes of legal matters and settlements, net, in 2024, restructuring actions in both years, and transaction and related costs in 2023 | $ | 4.8 | $ | 3.6 | |||||||
20
Avery Dennison Corporation
Net Sales
The factors impacting reported net sales change are shown in the table below.
| Three Months Ended | |||||
| March 30, 2024 | |||||
| Reported net sales change | 8 | % | |||
| Foreign currency translation | 2 | ||||
Sales change ex. currency(1) | 10 | ||||
| Acquisitions | (4) | ||||
Organic sales change(1) | 6 | % | |||
(1) Totals may not sum due to rounding. | |||||
In the first quarter of 2024, on an organic basis, sales increased compared to the same period in the prior year by a low double-digit rate in high value categories and a low single-digit rate in the base business. Company-wide, on an organic basis, sales of Intelligent Label solutions increased by a mid-to-high teens rate compared to the same period in the prior year.
Operating Income
Operating income increased in the first quarter of 2024 compared to the same period last year primarily due to higher volume and benefits from productivity initiatives, including savings from restructuring actions, net of transition costs, partially offset by higher employee-related costs and growth investments.
FINANCIAL CONDITION
Liquidity
Operating Activities
| Three months ended | |||||||||||
| (In millions) | March 30, 2024 | April 1, 2023 | |||||||||
| Net income | $ | 172.4 | $ | 121.2 | |||||||
| Depreciation | 49.0 | 44.8 | |||||||||
| Amortization | 28.3 | 27.5 | |||||||||
| Provision for credit losses and sales returns | 11.8 | 10.6 | |||||||||
| Stock-based compensation | 7.5 | 10.5 | |||||||||
| Deferred taxes and other non-cash taxes | (3.0) | (4.5) | |||||||||
| Other non-cash expense and loss (income and gain), net | 18.1 | 10.1 | |||||||||
| Changes in assets and liabilities and other adjustments | (164.3) | (218.3) | |||||||||
| Net cash provided by operating activities | $ | 119.8 | $ | 1.9 | |||||||
During the first three months of 2024, net cash provided by operating activities increased compared to the same period last year primarily due to higher net income, lower incentive compensation payments and lower tax payments, net of refunds.
Investing Activities
| Three months ended | |||||||||||
(In millions) | March 30, 2024 | April 1, 2023 | |||||||||
| Purchases of property, plant and equipment | $ | (48.8) | $ | (64.5) | |||||||
| Purchases of software and other deferred charges | (6.9) | (5.3) | |||||||||
Purchases of Argentine Blue Chip Swap securities | (20.2) | — | |||||||||
Proceeds from sales of Argentine Blue Chip Swap securities | 14.0 | — | |||||||||
| Proceeds from sales of property, plant and equipment | .1 | .2 | |||||||||
| Proceeds from insurance and sales (purchases) of investments, net | .1 | (3.5) | |||||||||
Payments for acquisitions, net of cash acquired, and venture investments | (.3) | (43.5) | |||||||||
| Net cash used in investing activities | $ | (62.0) | $ | (116.6) | |||||||
21
Avery Dennison Corporation
Purchases of Property, Plant and Equipment
During the first three months of 2024, in our Materials Group reportable segment, we primarily invested in buildings and equipment to support growth in the U.S. and in certain countries in Europe, primarily France; in our Solutions Group reportable segment, we primarily invested in buildings and equipment in certain countries in Asia Pacific, including Vietnam and China, in the U.S. and in certain countries in Latin America, primarily Mexico. During the first three months of 2023, in our Materials Group reportable segment, we primarily invested in buildings and equipment to support growth in certain countries in Europe, including France and the Netherlands, in the U.S. and in certain countries in Latin America, primarily Brazil; in our Solutions Group reportable segment, these investments were made in certain countries in Latin America, primarily Mexico, and Asia, including Malaysia, Hong Kong and China, and in the U.S.
Purchases of Software and Other Deferred Charges
During the first three months of 2024 and 2023, we primarily invested in information technology upgrades in the U.S.
Purchases and Proceeds from Sales of Argentine Blue Chip Swap Securities
During the first three months of 2024, we entered into Blue Chip Swap transactions that resulted in losses of approximately $6 million. Refer to Note 12, “Supplemental Financial Information,” to the unaudited Condensed Consolidated Financial Statements for more information.
Payments for Acquisitions, Net of Cash Acquired, and Venture Investments
During the first three months of 2023, we paid consideration, net of cash acquired, of approximately $44 million for the acquisition of Thermopatch, Inc. ("Thermopatch"). We funded the Thermopatch acquisition using cash and commercial paper borrowings.
Financing Activities
| Three months ended | |||||||||||
(In millions) | March 30, 2024 | April 1, 2023 | |||||||||
| Net increase (decrease) in borrowings with maturities of three months or less | $ | 15.9 | $ | 42.9 | |||||||
| Additional long-term borrowings | — | 394.9 | |||||||||
| Repayments of long-term debt and finance leases | (1.7) | (1.4) | |||||||||
| Dividends paid | (65.3) | (60.8) | |||||||||
| Share repurchases | (15.6) | (50.7) | |||||||||
| Net (tax withholding) proceeds related to stock-based compensation | (18.3) | (23.6) | |||||||||
| Other | — | (1.5) | |||||||||
Net cash (used in) provided by financing activities | $ | (85.0) | $ | 299.8 | |||||||
Borrowings and Repayment of Debt
During the first three months of 2024 and 2023, our commercial paper borrowings were used to fund acquisitions, dividend payments, share repurchases, capital expenditures and other general corporate purposes.
In March 2023, we issued $400 million of senior notes, due March 15, 2033, which bear an interest rate of 5.750% per year, payable semiannually in arrears. Our net proceeds from this issuance, after deducting underwriting discounts and offering expenses, were $394.9 million, which we used to repay both existing indebtedness under our commercial paper programs and the $250 million aggregate principal amount of senior notes that matured on April 15, 2023.
Refer to Note 3, “Debt,” to the unaudited Condensed Consolidated Financial Statements for more information.
Dividends Paid
We paid dividends of $0.81 per share in the first three months of 2024 compared to $0.75 per share in the same period last year. In April 2024, subsequent to the end of our first quarter 2024, we increased our quarterly dividend rate to $0.88 per share, representing an increase of approximately 9% from our previous quarterly dividend rate of $0.81 per share.
Share Repurchases
During the first three months of 2024 and 2023, we repurchased approximately 0.1 million and 0.3 million shares of our common stock, respectively.
Long-lived Assets
In the three months ended March 30, 2024, goodwill decreased by approximately $20 million to $1.99 billion, primarily reflecting the impact of foreign currency translation.
In the three months ended March 30, 2024, other intangibles resulting from business acquisitions, net, decreased by approximately $25 million to $823.8 million, reflecting current year amortization expense and the impact of foreign currency translation.
22
Avery Dennison Corporation
Refer to Note 2, “Goodwill and Other Intangibles Resulting from Business Acquisitions,” to the unaudited Condensed Consolidated Financial Statements for more information.
Shareholders’ Equity Accounts
As of March 30, 2024, the balance of our shareholders’ equity was $2.20 billion. Refer to Note 8, “Supplemental Equity and Comprehensive Income Information,” to the unaudited Condensed Consolidated Financial Statements for more information.
Impact of Foreign Currency Translation
| Three Months Ended | |||||
| (In millions) | March 30, 2024 | ||||
| Change in net sales | $ | (1) | |||
International operations generated approximately 70% of our net sales during the three months ended March 30, 2024. Our future results are subject to changes in political, social and economic conditions globally and in the regions in which we operate and the impact of fluctuations in foreign currency exchange and interest rates.
The unfavorable impact of foreign currency translation on net sales in the first three months of 2024 compared to the same period last year was primarily related to sales in China, partially offset by euro-denominated sales.
Effect of Foreign Currency Transactions
The impact on net income from transactions denominated in foreign currencies is largely mitigated because the costs of our products are generally denominated in the same currencies in which they are sold. In addition, to reduce our income and cash flow exposure to transactions in foreign currencies, we enter into foreign exchange forward, option and swap contracts where available and appropriate. Refer to Note 5, “Financial Instruments,” to the unaudited Condensed Consolidated Financial Statements for more information.
Analysis of Selected Financial Ratios
We utilize the financial ratios discussed below to assess our financial condition and operating performance. We believe this information assists our investors in understanding the factors impacting our cash flow other than net income and capital expenditures.
Operational Working Capital Ratio
Operational working capital, as a percentage of annualized current-quarter net sales, is reconciled to working capital (deficit) below. Working capital (deficit) (current assets minus current liabilities) as of the first quarter 2024 decreased by approximately $767 million compared to the first quarter of 2023 primarily due to the reclassification of our $300 million of senior notes due in the third quarter of 2024 and €500 million of senior notes due in the first quarter of 2025 as well as an increase of approximately $48 million related to the contingent liability for the Adasa legal matter. Our objective is to minimize our investment in operational working capital, as a percentage of annualized current-quarter net sales, to maximize cash flow and return on investment. As shown below, operational working capital, as a percentage of annualized current-quarter net sales, in the first quarter of 2024 decreased compared to the first quarter of 2023.
| (In millions, except percentages) | March 30, 2024 | April 1, 2023 | |||||||||
(A) Working capital (deficit) | $ | (421.4) | $ | 345.5 | |||||||
| Reconciling items: | |||||||||||
| Cash and cash equivalents | (185.7) | (351.3) | |||||||||
| Other current assets | (250.6) | (218.2) | |||||||||
| Short-term borrowings and current portion of long-term debt and finance leases | 1,170.5 | 648.3 | |||||||||
| Accrued payroll and employee benefits and other current liabilities | 836.2 | 759.2 | |||||||||
| (B) Operational working capital | $ | 1,149.0 | $ | 1,183.5 | |||||||
(C) First-quarter net sales, annualized | $ | 8,605.2 | $ | 8,260.0 | |||||||
| Operational working capital, as a percentage of annualized current-quarter net sales: (B) ÷ (C) | 13.4 | % | 14.3 | % | |||||||
Accounts Receivable Ratio
The average number of days sales outstanding was 63 days in the first quarter of 2024 compared with 60 days in the first quarter of 2023, calculated using the accounts receivable balance at quarter-end divided by the average daily sales in the respective quarter. The increase in average number of days sales outstanding was primarily due to the timing of collections, partially offset by foreign currency translation.
23
Avery Dennison Corporation
Inventory Ratio
Average inventory turnover was 6.2 in the first quarter of 2024 compared to 5.8 in the first quarter of 2023, calculated using the annualized first-quarter cost of products sold in 2024 and 2023, respectively, and divided by the inventory balance at quarter-end. The increase in average inventory turnover primarily reflected the impact of higher prior-year inventory balances due to customer inventory destocking.
Accounts Payable Ratio
The average number of days payable outstanding was 78 days in the first quarter of 2024 compared to 74 days in the first quarter of 2023, calculated using the accounts payable balance at quarter-end divided by the respective annualized first-quarter cost of products sold. The increase in average number of days payable outstanding primarily reflected the timing of vendor payments, partially offset by the impact of foreign currency translation.
Capital Resources
Capital resources include cash flows from operations, cash and cash equivalents and debt financing, including access to commercial paper borrowings supported by our $1.20 billion revolving credit facility (the “Revolver”). We use these resources to fund our operational needs.
As of March 30, 2024, we had cash and cash equivalents of $185.7 million held in accounts at third-party financial institutions. Our cash balances are held in numerous locations around the world. As of March 30, 2024, the majority of our cash and cash equivalents was held by our foreign subsidiaries, primarily in the Asia Pacific region.
To meet our U.S. cash requirements, we have several cost-effective liquidity options available. These options include borrowing funds at reasonable rates, including borrowings from foreign subsidiaries, and repatriating foreign earnings and profits. However, if we were to repatriate foreign earnings and profits, a portion would be subject to cash payments of withholding taxes imposed by foreign tax authorities. Additional U.S. taxes may also result from the impact of foreign currency fluctuations related to these earnings and profits.
The Revolver, which matures in February 2026, is used as a back-up facility for our commercial paper borrowings and can be used for other corporate purposes. No balance was outstanding under the Revolver as of March 30, 2024 or December 30, 2023.
We are currently considering various sources, including cash flows from operations, commercial paper borrowings and other financings, to repay approximately $300 million of senior notes and €500 million of senior notes maturing in the third quarter of 2024 and first quarter of 2025, respectively.
Capital from Debt
The carrying value of our total debt decreased by approximately $4 million in the first three months of 2024 to $3.24 billion.
Credit ratings are a significant factor in our ability to raise short- and long-term financing. The credit ratings assigned to us also impact the interest rates we pay and our access to commercial paper, credit facilities and other borrowings. A downgrade of our short-term credit ratings could impact our ability to access commercial paper markets. If our access to commercial paper markets were to become limited, we believe that the Revolver and our other credit facilities would be available to meet our short-term funding requirements. When determining a credit rating, we believe that rating agencies primarily consider our competitive position, business outlook, consistency of cash flows, debt level and liquidity, geographic dispersion and management team. We remain committed to maintaining an investment grade rating.
Off-Balance Sheet Arrangements, Contractual Obligations, and Other Matters
Refer to Note 10, “Commitments and Contingencies,” to the unaudited Condensed Consolidated Financial Statements for this information. Except as indicated therein, we have no material off-balance sheet arrangements as described in Item 303(b) of Regulation S-K.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
There have been no material changes to the information provided in Part II, Item 7A of our Annual Report on Form 10-K for the fiscal year ended December 30, 2023 that have not been disclosed in our periodic filings with the U.S. Securities and Exchange Commission (SEC).
24
Avery Dennison Corporation
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(f)) that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding the required disclosure.
In designing and evaluating the disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
Our disclosure controls system is based upon a global chain of financial and general business reporting lines that converge in our headquarters in Mentor, Ohio. As required by SEC Rule 13a-15(b), we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the quarter covered by this report. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of such time to provide reasonable assurance that information was recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information was accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding the required disclosure.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
25
Avery Dennison Corporation
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
Refer to “Legal Proceedings” in Note 10, “Commitments and Contingencies,” to the unaudited Condensed Consolidated Financial Statements in Part 1, Item 1 for this information.
ITEM 1A. RISK FACTORS
There have been no material changes to the risk factors included in Part I, Item 1A, of our Annual Report on Form 10-K for the fiscal year ended December 30, 2023 that have not been disclosed in our periodic filings with the SEC.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
(a)Not Applicable
(b)Not Applicable
(c)Repurchases of Equity Securities by Issuer
Repurchases by us or our “affiliated purchasers” (as defined in Rule 10b-18(a)(3) of the Exchange Act) of registered equity securities in the first quarter of 2024 are shown in the table below. Repurchased shares may be reissued under our long-term incentive plan or used for other corporate purposes.
Period(1) | Total number of shares purchased(2) | Average price paid per share(3) | Total number of shares purchased as part of publicly announced plans(2)(4) | Approximate dollar value of shares that may yet be purchased under the plans(4)(5) | |||||||||||||||||||
| December 31, 2023 – January 27, 2024 | — | $ | — | — | $ | 592.8 | |||||||||||||||||
| January 28, 2024 – February 24, 2024 | 3.8 | 197.51 | 3.8 | 592.0 | |||||||||||||||||||
| February 25, 2024 – March 30, 2024 | 68.3 | 216.75 | 68.3 | 577.2 | |||||||||||||||||||
| Total | 72.1 | $ | 215.73 | 72.1 | $ | 577.2 | |||||||||||||||||
(1)The periods shown are our fiscal periods during the thirteen-week quarter ended March 30, 2024.
(2)Shares in thousands.
(3)Average price paid per share includes transaction costs to acquire the shares and excludes the non-deductible 1% excise tax on the net value of repurchases imposed under the Inflation Reduction Act of 2022.
(4)In April 2022, our Board authorized the repurchase of shares of our common stock with a fair market value of up to $750 million, excluding any fees, commissions or other expenses related to such purchases, in addition to the amount outstanding under our previous Board authorization. Board authorizations remain in effect until shares in the amount authorized thereunder have been repurchased.
(5)Dollars in millions.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
Not Applicable
ITEM 4. MINE SAFETY DISCLOSURES
Not Applicable
ITEM 5. OTHER INFORMATION
On March 14, 2024 , Mitchell R. Butier , our Executive Chairman , adopted a Rule 10b5-1 trading plan. Mr. Butier's trading plan provides for the potential exercise and sale of up to 15,000 shares of our common stock subject to stock options, until February 28, 2025. This plan is intended to satisfy the affirmative defense of Rule 10b-1(c) under the Securities Exchange Act of 1934, as amended, and our insider trading policy.
There were no other Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements (as defined in Item 408(c) of Regulation S-K) adopted or terminated
26
Avery Dennison Corporation
ITEM 6. EXHIBITS
Exhibit 10.1*† | |||||
| Exhibit 31.1* | |||||
| Exhibit 31.2* | |||||
| Exhibit 32.1** | |||||
| Exhibit 32.2** | |||||
| Exhibit 101.INS*** | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | ||||
| Exhibit 101.SCH*** | Inline XBRL Extension Schema Document | ||||
| Exhibit 101.CAL*** | Inline XBRL Extension Calculation Linkbase Document | ||||
| Exhibit 101.LAB*** | Inline XBRL Extension Label Linkbase Document | ||||
| Exhibit 101.PRE*** | Inline XBRL Extension Presentation Linkbase Document | ||||
| Exhibit 101.DEF*** | Inline XBRL Extension Definition Linkbase Document | ||||
| Exhibit 104*** | Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included as part of this Exhibit 101 Inline XBRL document set | ||||
____________________
| † | Management contract or compensatory plan or arrangement required to be filed as an exhibit to this Form 10-Q. | ||||
| * | Filed herewith. | ||||
| ** | Furnished herewith. | ||||
| *** | Furnished herewith. Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act, are deemed not filed for purposes of Section 18 of the Exchange Act and otherwise are not subject to liability under those sections. | ||||
27
Avery Dennison Corporation
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| AVERY DENNISON CORPORATION | |||||
| (Registrant) | |||||
| /s/ Gregory S. Lovins | |||||
| Gregory S. Lovins | |||||
| Senior Vice President and Chief Financial Officer | |||||
| (Principal Financial Officer) | |||||
| /s/ Divina F. Santiago | |||||
| Divina F. Santiago | |||||
Vice President, Controller | |||||
| (Principal Accounting Officer) | |||||
April 30, 2024 | |||||
28
Exhibit 10.1
8080 Norton Parkway
Mentor, OH 44060
Phone 440-534-6000
February 12, 2024
Ryan Yost
[Address]
[Address]
Dear Ryan:
I am very pleased to confirm your appointment as President, Materials Group, effective March 1, 2024, reporting to me. This is an Executive Level 2 position and is subject to approval by the Board of Directors (the “Board”) on February 22, 2024; the compensation package described in this letter was approved by the Board’s Talent and Compensation Committee (the “Committee”) on February 7, 2024.
Specific details of your compensation are as follows:
Base Salary: Your annualized rate of pay will be $525,000, paid pursuant to customary US payroll practices. Your next salary review will be April 2025. Subsequent salary reviews will be conducted in April of each year, or on another date designated by the Company for a given year.
AIP Award: You will continue to be eligible to participate in the Company’s Annual Incentive Plan (“AIP”), now with a target AIP opportunity of 60% of base salary, subject to applicable withholdings. The AIP, including eligibility criteria, may change at any time, with or without notice, in accordance with applicable law and at the discretion of the Company.
Long-Term Incentive (LTI): You will be eligible for an annual LTI award with a target opportunity of 180% of base salary, effective with the 2024 annual LTI grant. Executive LTI awards are currently delivered via a mix of Performance Units and Market-Leveraged Stock Units. The LTI program, including eligibility criteria, may change at any time, with or without notice, in accordance with applicable law and at the discretion of the Company.
Special Promotion Awards: In addition to the 2024 annual award, the Committee has approved the following one-time special promotion awards:
●A one-time award of RSUs with a grant date fair value of $700,000 to be awarded on March 1, 2024. This award will vest in full on the third anniversary of the grant date, subject to your continued employment with the Company through such anniversary.
●A one-time award of PUs with a grant date fair value of $300,000 to be awarded on March 1, 2024. The performance objectives and weightings of this award will be 50% company cumulative EVA and 50% Relative TSR. This award will be eligible for vesting at the end of the performance period on January 1, 2027, subject to your continued employment with the Company and performance results.
Executive Benefits: You will receive an annual executive benefit allowance (EBA) in the amount of $65,000, effective March 1, 2024, which will be paid with your normal payroll cycle. You will also be entitled to the benefits generally available to a Company Level 2 US-based executive.
Stock Ownership Requirement: Beginning March 1, 2024, you will be required to comply with the Company’s Stock Ownership Policy with an ownership requirement of 3X your base salary. You must achieve and maintain this ownership requirement in accordance with the policy, which, among other things, gives you five years from the date of your promotion to achieve the requisite level.
Vacation: You will be entitled to unlimited vacation. You will not accrue vacation while eligible for the unlimited use program.
Section 16 Designation: Effective March 1, 2024, you will be designated as a Section 16 officer under U.S. securities laws. As a result, you will have obligations to report any transactions you make with respect to Company stock within two business days of the transaction. In addition to these reporting requirements, you can be subject to civil liability for certain “short-swing” transactions. You should discuss these matters with the Company’s Corporate Secretary.
As a condition of your promotion, we need to receive a signed and dated copy of this letter.
Congratulations on your well deserved promotion. If you have any questions, please let me know.
Sincerely,
/s/ Deon Stander
Deon Stander
President & CEO
Attachments
Level 2 US-Based Executive Benefit Summary
Stock Ownership Policy
cc: Deena Baker-Nel, SVP & CHRO
Accepted by: /s/ Ryan Yost
Date: February 22, 2024
Avery Dennison Corporation
Exhibit 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
CERTIFICATION
I, Deon M. Stander, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Avery Dennison Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
| /s/ | Deon M. Stander | |||||||
Deon M. Stander President and Chief Executive Officer | ||||||||
April 30, 2024 | ||||||||
Avery Dennison Corporation
Exhibit 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
CERTIFICATION
I, Gregory S. Lovins, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Avery Dennison Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
| /s/ | Gregory S. Lovins | |||||||
| Gregory S. Lovins Senior Vice President and Chief Financial Officer | ||||||||
April 30, 2024 | ||||||||
Avery Dennison Corporation
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER*
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Avery Dennison Corporation (the “Company”) hereby certifies, to the best of his knowledge, that:
(i)the Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended March 30, 2024 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: April 30, 2024 | ||||||||
| /s/ | Deon M. Stander | |||||||
Deon M. Stander President and Chief Executive Officer | ||||||||
*The above certification accompanies the Company’s Quarterly Report on Form 10-Q and is furnished, not filed, as provided in SEC Release 33-8238, dated June 5, 2003.
Avery Dennison Corporation
Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER*
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Avery Dennison Corporation (the “Company”) hereby certifies, to the best of his knowledge, that:
(i)the Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended March 30, 2024 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: April 30, 2024 | ||||||||
| /s/ | Gregory S. Lovins | |||||||
| Gregory S. Lovins Senior Vice President and Chief Financial Officer | ||||||||
*The above certification accompanies the Company’s Quarterly Report on Form 10-Q and is furnished, not filed, as provided in SEC Release 33-8238, dated June 5, 2003.